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INTRODUCTION
Septic shock is accompanied by activation of the hypotha-
lamic-pituitary-adrenal axis, as demonstrated by an increased
serum cortisol concentration (1), and this activation is the
essential component of the general adaptation to stress. Cor-
tisol has a vital supportive role in the maintenance of vascu-
lar tone, endothelial integrity, vascular permeability, and the
distribution of total body water within the vascular compart-
ment (2-4), and also potentiates the vasoconstrictor actions
of catecholamines (2, 4). Cortisol levels considered normal
or above normal may not be sufficient in critically ill patients
(5), and insufficient cortisol secretion related to illness severi-
ty is referred to as relative adrenal insufficiency (RAI).
Increasing evidence indicates that RAI occurs in critically
ill patients with septic shock and that low-dose corticosteroids
may improve outcomes in these patients (6). Diagnosis of
RAI is difficult because the expected cortisol levels vary with
the type and severity of disease (5, 7) and with different serum
levels of binding proteins (8). Cortisol demonstrates different
degrees of tissue resistance (9) and cortisol levels vary with
the time of blood sampling because of the pulsatile nature
of cortisol secretion. In addition, the incidence of RAI may
vary according to the diagnostic test performed and the cri-
teria used to establish the diagnosis. In several studies, low
levels of random serum cortisol were used to diagnose RAI,
using a cutoff value between 15 and 25  g/dL (10-13). How-
ever, increases in cortisol levels <9  g/dL after corticotropin
stimulation have been associated with vascular unresponsive-
ness to catecholamines (14, 15) and with an increased risk
of death (5). Cortisol replacement has been shown to restore
vessel reactivity to vasopressor agents and to improve survival
(6, 14). Thus, although increases in the cortisol level <9  g/
dL after corticotropin stimulation is most often used to define
RAI, rapid ACTH stimulation test takes time and needs three
samples of blood making it cumbersome to perform. If cor-
tisol response to corticotropin stimulation can be predicted
by some clinical factors, for example, basal cortisol level, it
will be very helpful for clinicians at the bedside to make a
decision, but up to now no such variables have been defined.
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Basal Serum Cortisol Levels are not Predictive of Response to 
Corticotropin but Have Prognostic Significance in Patients with Septic
Shock
Because high levels of cortisol are frequently observed in patients with septic shock,
low levels of serum cortisol are considered indicative of relative adrenal insufficien-
cy (RAI). This study was performed to investigate whether pretest clinical charac-
teristics, including basal serum cortisol levels, are predictive of serum cortisol res-
ponse to corticotropin and whether basal cortisol levels have a prognostic signifi-
cance in patients with septic shock. We performed a retrospective analysis of 68
patients with septic shock who underwent short corticotropin stimulation testing.
RAI was defined as an increase in cortisol level <9  g/dL from baseline, and results
showed that 48 patients (70.6%) had this insufficiency. According to the univariate
analysis, the RAI group had significantly higher simplified acute physiology score II
(SAPS II) and sequential organ failure assessment (SOFA) scores than the non-RAI
group. The incidence of RAI was the same regardless of the basal serum cortisol
level (p=0.447). The hospital mortality rate was 58.8% and was not significantly dif-
ferent between the RAI and non-RAI groups. However, a high basal serum cortisol
level (≥ ≥30  g/dL) was significantly associated with in-hospital mortality. In conclu-
sion, our data suggest that basal serum cortisol levels are not predictive of serum
cortisol response to corticotropin but have a significant prognostic value in patients
with septic shock.
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The aim of this study was to determine whether pretest
clinical factors, including basal cortisol levels, are predictive
of cortisol response to standard short corticotropin testing
and to assess the significance of basal cortisol levels as a prog-
nostic indicator in patients with septic shock.
MATERIALS AND METHODS
Study population
Sixty-eight patients with septic shock who underwent short
corticotropin stimulation testing at Samsung Medical Center,
in Seoul, Republic of Korea, between January 2004 and August
2005 were retrospectively enrolled in the study. All of the
patients met the Society of Critical Care Medicine/American
College of Chest Physicians criteria of septic shock (16). None
of the patients were taking corticosteroids, etomidate, keto-
conazole, or other drugs known to suppress adrenal function.
Diagnosis of RAI
The short corticotropin stimulation test was performed by
administering 250  g of synthetic corticotropin intravenously
and obtaining serum samples for cortisol before and 30 and
60 min following corticotropin administration. RAI was dia-
gnosed when the peak cortisol concentration after corticotro-
pin administration was <9  g/dL from baseline either at 30
min or 60 min. 
Data collection and analysis
The patient’s clinical and laboratory data were recorded
with a retrospective chart review. The severity of illness was
assessed by simplified acute physiology score II (SAPS II) and
sequential organ failure assessment (SOFA) score at the time
of short corticotropin stimulation test. Statistical analyses
were performed with SPSS 11.0 (SPSS, Chicago, IL, U.S.A.).
Values were expressed as means±standard deviations, or as
numbers (percentages) in the text and tables. Chi-square anal-
ysis with Fisher’s exact test (when appropriate) was used to
compare categorical data. Continuous data were compared
with Student’s t-test. Logistic regression was used to calcu-
late the odds ratios of risk factors and a log-rank test was used
to evaluate factors associated with survival. Cox proportion-
al hazard model was used to evaluate relative risk for survival.
Statistical significance was established at p<0.05. 
RESULTS
Patients characteristics
Of the 68 patients with septic shock, 20 were female and
48 were male. The mean age of the patients was 60±14 yr,
and 40 patients (58.8%) died. The mean SAPS II and SOFA
scores were 54±14 and 12±4, respectively. The mean basal
serum cortisol level was 23±14  g/dL. In total, 48 patients
(70.6%) were diagnosed with RAI. Short corticotropin stim-
ulation test was performed at median 16.1 hr (0.2-137.3 hr)
after onset of septic shock. 
Factors predictive of RAI
Patient characteristics are shown in Table 1. SAPS II and
SOFA scores were significantly different between the RAI
and non-RAI groups (p=0.002 and p=0.015, respectively).
The lung was the most common site of origin for sepsis in
both groups. Bacterial infection was the most common cause
of sepsis. The incidence of Gram-positive and Gram-nega-
tive bacterial infections was similar in both groups. Malig-
nancy was the most common comorbid illness (54% in RAI
group and 40% in the non-RAI group) and refractory shock
was the most common cause of death in both groups, with
RAI, relative adrenal insufficiency; SAPS II, simplified acute physiology
score II; SOFA, sequential organ failure assessment; G(+), Gram-posi-
tive bacteria; G(-), Gram-negative bacteria; HTN, hypertension; IHD,
ischemic heart disease; CHF, congestive heart failure; DM, diabetes
mellitus; CRF, chronic renal failure; CNS, central nervous system. Val-
ues are expressed as the mean±SD.
Non- RAI 
(n=20)
RAI 
(n=48)
p value
Sex (M:F) 2.3:1 2.4:1 0.945
Age (yr) 58±15 62±14 0.295
SAPS II score  46±14 57±13 0.002
SOFA score  11±31 3 ±4 0.015
Basal cortisol ( g/dL) 20±14 24±15 0.324
Mortality 50% 62.5% 0.340
Site of sepsis
Lung 15 25 0.141
Abdominoperitoneal 2 14
Urinary tract 3 4
Unknown 0 2
Other 2 13
Isolated organism
G(+) 5 15 0.208
G(-) 5 16
Fungus 3 1
Other 1 2
Comorbid illnesses
Cancer 8 26 0.656
Cardiovascular disease 6 11
CNS disease 2 6
Other 12 21
Cause of death
Septic shock 7 27 0.198
Respiratory failure 2 1
Other 1 2
Table 1. Clinical data, sites of sepsis, and bacterial strains diag-
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no significant differences between the groups.
The incidence of RAI was 62.5, 79.2, and 70.0% for patients
with basal cortisol levels <15, 15-30, and ≥30 g/dL,  respec-
tively (p=0.447) (Table 2). To assess the influence of diurnal
variation on the result of short corticotropin stimulation test,
the incidence of RAI was analyzed according to the time of
corticotropin injection. Eight, 47, and 13 patients, respectively,
had the test performed between 0:00-8:00, 8:00-16:00, and
16:00-24:00. The incidence of RAI was 75%, 70%, and 69%,
respectively showing no significant difference among three
groups (p=0.956). The influence of time lag from the onset
of septic shock to the actual start of short corticotropin stimu-
lation test was also assessed. Patients whose time lag was <12
hr, 12-24 hr, 24-48 hr, and >48 hr had RAI in 70% (17/23),
62% (16/26), 75% (9/12), and 86% (6/7) of patients, respec-
tively, showing no statistically significant difference (p=0.566).
According to the multivariate analysis with logistic regres-
sion, no variable was predictive of RAI (Table 3).
Corticosteroid replacement therapy
Among patients with RAI, 33 (68.8%) received low-dose
corticosteroid replacement therapy (hydrocortisone sodium
succinate 50 mg every 6 hr for 7 days). No significant differ-
ence in mortality was observed between patients who received
corticosteroid replacement therapy and those who did not
(73% [11/15] vs. 58% [19/33], p=0.351).
Factors related to survival
A univariate analysis was performed to compare the char-
acteristics of survivors versus non-survivors (Table 4). A higher
SAPS II score (48 in the survival group vs. 58 in the non-
survival group, p=0.006) and lower arterial pH (7.3 in the
survival group vs. 7.2 in the non-survival group, p=0.010)
were significantly associated with hospital mortality, accord-
ing to the univariate analysis. The survival group demon-
strated lower basal serum cortisol levels, although this find-
ing was not significant. Basal serum cortisol levels ≥30 g/
dL were significantly associated with hospital mortality in
the univariate analysis (85% mortality in patients with basal
RAI, relative adrenal insufficiency. RAI was diagnosed based on short
corticotropin test. 
Basal cortisol 
level ( g/dL)
RAI (cases/total 
numbers)
p value
<15 62.5% (15/24) 0.447
15-30 79.2% (19/24)
≥30 70.0% (14/20)
Total 70.6% (48/68)
Table 2. Incidence of RAI according to the basal cortisol levels
RAI, relative adrenal insufficiency; CI, confidence interval; SAPS II, simpli-
fied acute physiology score II; SOFA, sequential organ failure assessment.
Odds ratio 95% CI p value
Sex (F) 1.801 0.467-6.939 0.393
Age 1.002 0.957-1.049 0.938
SAPS II 1.065 0.994-1.141 0.073
SOFA 1.057 0.848-1.318 0.621
Basal cortisol 0.999 0.956-1.045 0.971
Hospital mortality  0.839 0.238-2.961 0.785
Table 3. Multivariate logistic regression analysis for the risk of
RAI
RAI, relative adrenal insufficiency; SAPS II, simplified acute physiology
score II; SOFA, sequential organ failure assessment.
Survivors 
(n=28)
Non-survivors 
(n=40)
Variable p value
Age (yr) 60±13 61±15 0.917
Sex (M:F) 3:1 2.1:1 0.504
Arterial pH 7.3±0.1 7.2±0.2 0.010
Basal cortisol ≥30 g/dL 3  (11%) 17  (43%) 0.006
RAI 64% 75% 0.340
SAPS II 48±16 58±12 0.006
SOFA 11.4±3.2 12.8±3.7 0.102
Table 4. Univariate analysis for survival
CI, confidence interval; RAI, relative adrenal insufficiency; SAPS II, sim-
plified acute physiology score II; SOFA, sequential organ failure assess-
ment.
Odds ratio 95% CI p value
Age 0.983 0.938-1.031 0.486
Sex (F) 3.306 0.736-14.842 0.119
Arterial pH 0.019 0.000-4.486 0.155
Basal cortisol ≥30 g/dL 9.006 1.598-50.746 0.013
RAI 1.057 0.236-4.731 0.942
SAPS II 1.058 0.988-1.134 0.108
SOFA 0.974 0.733-1.295 0.858
Table 5. Multivariate logistic regression analysis for in-hospital
mortality
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Fig. 1. Kaplan-Meier analysis of the survival probability in patients
with septic shock. 
Basal cortisol ≥30
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serum cortisol ≥30  g/dL vs. 48% mortality in patients with
basal serum cortisol <30  g/dL, p=0.006). In addition, basal
serum cortisol levels ≥30  g/dL were significantly associ-
ated with hospital mortality in the multivariate logistic reg-
ression analysis (Table 5). The median time to death was 5
days for patients with basal cortisol levels >30  g/dL (95%
confidence interval [0.84, 9.16]) and 25 days for patients
with basal cortisol levels <30  g/dL (95% confidence inter-
val [10.2, 39.8], p=0.006) (Fig. 1).
DISCUSSION
Our findings suggest that RAI, diagnosed according to a
decreased cortisol response to corticotropin, is frequently
observed in Korean patients with septic shock. None of the
pretest clinical factors evaluated were predictive of RAI. Al-
though basal cortisol levels were not predictive of response
to corticotropin, they still had a prognostic value in patients
with septic shock, many of whom had received corticosteroid
replacement therapy.
To our knowledge, this is the first study reporting the
incidence of RAI in Korean patients with septic shock. The
incidence of RAI in septic shock was 70.6%, which is con-
sistent with the findings of Annane et al. (6), demonstrat-
ing that RAI is a major clinical problem in Korean patients
with septic shock.
Tests such as the random serum cortisol level, short corti-
cotropin stimulation, low-dose short corticotropin stimula-
tion, insulin-induced hypoglycemia, and short metyrapone
have been used to diagnose adrenal insufficiency in different
patient populations (17). The short corticotropin stimulation
test is the most commonly performed test for the diagnosis
of primary adrenal insufficiency (18, 19). However, it is limit-
ed when hypoadrenalism occurs secondary to recent hypo-
thalamic or pituitary insults and caution is necessary when
interpreting the test results (17). Theoretically, evaluation
of the integrity of the whole hypothalamic-pituitary-adrenal
axis is best served by cortisol response to insulin-induced
hypoglycemia (20). However, insulin-induced hypoglycemia
may pose risks to patients with ischemic heart disease, epilep-
sy, or severe cortisol deficiency (10) and may be life-threat-
ening in patients with unstable hemodynamics, such as those
with septic shock.
The optimal means of diagnosing RAI in critically ill pa-
tients remains controversial. The simplest method is to test
a random cortisol level. In an otherwise stable person, a ran-
dom serum cortisol level ≤3  g/dL is suggestive of adrenal
insufficiency, whereas an adrenal insufficiency may be ruled
out with a random cortisol level ≥19  g/dL (18). However,
in critically ill patients, basal serum cortisol levels are usually
elevated and correlated with the severity of illness (5), which
makes determining an appropriate response difficult. Older
studies of RAI have used different levels of cortisol to establish
an accurate diagnosis, but none of them have been universally
accepted (21).
In this study, we defined RAI as an increase in cortisol level
<9  g/dL from baseline after corticotropin infusion because
it has been associated with increased mortality. In addition,
corticosteroid replacement therapy has been shown to improve
hemodynamics and survival in patients diagnosed with RAI
according to this criterion (5, 6, 14), suggesting that it may
have clinical utility in diagnosing RAI in patients with sep-
tic shock. A 250- g/dL dose of corticotropin is supraphysi-
ological, and some data suggest that low-dose testing with
1- g/dL may be more sensitive (22, 23); however, no data
are available on the significance of RAI diagnosed with low-
dose testing on clinically important endpoints. Notably, a
recent study by Marik et al. showed evidence that random
serum cortisol levels of <25  g/dL were more sensitive in
predicting hemodynamic responses to hydrocortisone in pa-
tients with septic shock than short corticotropin testing using
a low or high dose (12). However, in this study, only 22% of
patients with septic shock had a decreased response to a stan-
dard dose of corticotropin compared to 70.6% in our study
and 76.6% in the study by Annane et al. (6). These findings
suggest that the patient population studied by Marik et al.
was somewhat different from ours and that of Annane et al. 
No specific clinical features can help predict RAI in criti-
cally ill patients (17, 24). Although symptoms such as fatigue,
weight loss, nausea, abdominal pain, arthralgia, and postu-
ral syncope are known to be associated with hypoadrenalism,
these are nonspecific and frequently found in critically ill
patients (10). Similarly, classic features of addisonian crisis,
such as anorexia, nausea, vomiting, diarrhea, delirium, fever,
and hypotension, are common in sepsis patients (10). Hemo-
dynamic instability despite adequate fluid resuscitation and
ongoing evidence of inflammation without an obvious source
that does not respond to empirical treatment are also sugges-
tive of corticosteroid insufficiency in critically ill patients
(25, 26). However, these are also common features in patients
with severe sepsis/septic shock irrespective of the presence
of RAI. Thus, it is extremely difficult to recognize adrenal
insufficiency in patients who are under intensive care. In the
present study, none of the pretest clinical characteristics eval-
uated were predictive of RAI. SAPS II and SOFA scores were
significantly higher in the RAI group compared to the non-
RAI according to the univariate analysis; however, the mul-
tivariate analysis suggested that these differences were not
significant, although the SAPS II score had a borderline sig-
nificance (p=0.074). The utility of the SAPS II score in pre-
dicting RAI warrants further studies.
We evaluated whether a random serum cortisol level was
predictive of serum cortisol response to corticotropin. The
incidence of RAI, diagnosed as an increase in serum cortisol
level <9  g/dL measured 30-60 min after corticotropin in-
fusion, was similar among all patients irrespective of the basal
cortisol level. Even in patients with the highest random serum474 Y.S. Kwon, G.Y. Suh, E.-H. Kang, et al.
cortisol levels (≥30  g/dL), a similar proportion of patients
was observed as having a decreased cortisol response to cor-
ticotropin (70%). These data suggest that even when serum
cortisol is at a high level, patients may not retain the capa-
bility to further increase its secretion in response to physio-
logic needs.
The highest levels of cortisol in critically ill patients have
been reported in those with the highest illness severity scores
and those with the highest mortality rates (27, 28). More-
over, serum cortisol level has been shown to be an indepen-
dent predictor of outcome (5, 29). The prognostic impor-
tance of a high serum cortisol level may be different in patients
receiving corticosteroid replacement therapy due to the influ-
ence of the corticosteroid drug. Data from our study popu-
lation, in which more than two-thirds of patients received
corticosteroid replacement therapy, suggest that a random
cortisol level >30  g/dL holds prognostic significance.
The present study had several limitations. Not all of the
patients with septic shock underwent short corticotropin
stimulation testing during the study period. However, the
incidence of RAI (70.6%) and patient characteristics, such
as mean age, gender distribution, SAPS II score, basal corti-
sol level, site of infection, and isolated organisms, were con-
sistent with previous studies (5, 6). Second, not all of the
patients with RAI received treatment with corticosteroid
replacement therapy, as the decision to administer such treat-
ment was made by the attending physician. Thus, whether
corticosteroid replacement therapy improved outcomes in
these patients is beyond the scope of this study. But, it may
be one of the reasons why there was no significant mortality
difference between patients with and without RAI as had
been shown by a previous study (5). Third, since daily man-
agement of patients was done by different attending physi-
cians, different management strategies of individual septic
shock patient may have influenced the outcome of these pa-
tients. The patients were managed according to general prin-
ciples compatible with the ‘‘Surviving Sepsis Guideline’’ which
include early hemodynamic resuscitation, antibiotics thera-
py, drainage of septic focus, and use of vasopressor and an
intensivist was available everyday to provide guidance in gen-
eral critical care (30). But we cannot rule out the possibility
that these differences might have contributed to the results
of this study including the fact that SAPSII was not a prog-
nostic factor on multivariate analysis. 
In conclusion, none of the clinical characteristics we eval-
uated, including basal serum cortisol level, were predictive
of serum cortisol response to corticotropin. However, a high
basal cortisol level demonstrated prognostic significance in
patients with septic shock.
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